Treatment Resistant Alcohol Use Disorder

被引:0
|
作者
Patterson Silver Wolf, David A. [1 ]
Dulmus, Catherine N. [2 ]
Wilding, Gregory E. [3 ]
Yu, Jihnhee [3 ]
Barczykowski, Amy L. [3 ]
Shi, Tiange [3 ]
Diebold, Josal R. [2 ]
Harvey, Steven J. [4 ]
Tomasello, Nicole M. [4 ]
Linn, Braden K. [2 ]
机构
[1] Washington Univ, Brown Sch, St Louis, MO 63110 USA
[2] Univ Buffalo, Sch Social Work, 221 Parker Hall, Buffalo, NY 14214 USA
[3] Univ Buffalo, Biostat, Buffalo, NY USA
[4] Ipa Inc, Integr Partners Behav Hlth, Batavia, NY USA
关键词
Alcohol use disorder; treatment recycling; recidivism; treatment resistance; risk factors; treatment-as-usual; NATIONAL EPIDEMIOLOGIC SURVEY; DEPRESSION; NALTREXONE; DRINKING; RISK;
D O I
10.1080/07347324.2021.1989994
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Despite existing interventions that have shown some promise for people with alcohol use disorder (AUD), there is a sizable number of patients that fail to respond to or complete treatment. In the current study, we analyzed data from the Treatment Episode Data Set (TEDS) to create profiles that indicate who may be more likely to resist treatment-as-usual. For the analysis, chi-square and logistic regression were used to associate personal characteristics with being at high and low risk of treatment resistance. Characteristics that put someone at higher risk of resisting treatment-as-usual include being unemployed, homelessness (or a dependent living arrangement), using daily, being male, and co-occurring mental and substance abuse disorders. The results suggest that general demographic information at patients' admission can be used to identify population groups where conventional strategies for standard AUD treatment may be insufficient. As such, the findings can help to inform, shape, and personalize treatment, leading to successful outcomes for the subgroup of individuals who will not benefit from typical AUD interventions.
引用
收藏
页码:205 / 216
页数:12
相关论文
共 50 条
  • [21] PERSONALISING TOPIRAMATE TREATMENT FOR ALCOHOL USE DISORDER
    Kranzler, Henry R.
    DRUG AND ALCOHOL REVIEW, 2016, 35 : 6 - 6
  • [22] NEW DEVELOPMENTS IN THE TREATMENT OF ALCOHOL USE DISORDER
    Bonea, Maria
    Miclutia, Ioana Valentina
    FARMACIA, 2019, 67 (02) : 213 - 217
  • [23] Noradrenergic targets for the treatment of alcohol use disorder
    Carolina L. Haass-Koffler
    Robert M. Swift
    Lorenzo Leggio
    Psychopharmacology, 2018, 235 : 1625 - 1634
  • [24] BUNDLED PAYMENT FOR ALCOHOL USE DISORDER TREATMENT
    Quinn, A. E.
    Horgan, C. M.
    Hodgkin, D.
    Stewart, M.
    Brolin, M.
    Lane, N.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2015, 39 : 12A - 12A
  • [25] Pneumonia and alcohol use disorder: Implications for treatment
    Gupta, Niyati M.
    Deshpande, Abhishek
    Rothberg, Michael B.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (08) : 493 - 500
  • [26] Implication of Pharmacogenetics in Alcohol Use Disorder Treatment
    Hirapara, Ketan
    Aggarwal, Rashi
    Levounis, Petros
    Khan, Ghulam
    AMERICAN JOURNAL ON ADDICTIONS, 2016, 25 (04): : 316 - 316
  • [27] GABAB Agonists for the Treatment of Alcohol Use Disorder
    Mirijello, Antonio
    Caputo, Fabio
    Vassallo, Gabriele
    Rolland, Benjamin
    Tarli, Claudia
    Gasbarrini, Antonio
    Addolorato, Giovanni
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (23) : 3367 - 3372
  • [28] CHANGES IN TREATMENT FOR ALCOHOL USE DISORDER IN JAPAN
    Cho, T.
    Tanaka, M.
    Kobayashi, O.
    Iba, A.
    Yumoto, Y.
    Hashimoto, N.
    Muto, T.
    Fukuda, T.
    Tanaka, D.
    Noda, T.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 96A - 96A
  • [29] Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder
    Naglich, Andrew
    Adinoff, Bryon
    Brown, E. Sherwood
    CNS DRUGS, 2017, 31 (08) : 665 - 674
  • [30] Alcohol Use Disorder Treatment: Problems and Solutions
    Koob, George F.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2024, 64 : 255 - 275